Swedish 3D bioprinter manufacturer CELLINK has announced a strategic collaboration with microgravity manufacturing specialist Made In Space.
The aim of the collaboration is to identify 3D bioprinting development opportunities for the International Space Station (ISS) and future off-world platforms. The outcome of such projects is expected to have a real-world impact on drug screening and cancer research on Earth.
“CELLINK supports space programs in the United States with our deep commitment to cutting-edge innovation, extensive portfolio of technologies and world-class team of scientists and engineers,” comments Erik Gatenholm, co-founder and CEO of CELLINK
